IRIS
CIOTTA, Liliana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.906
EU - Europa 1.160
AS - Asia 1.046
AF - Africa 160
SA - Sud America 154
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 5.432
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.779
SG - Singapore 495
CN - Cina 435
IE - Irlanda 309
UA - Ucraina 306
IT - Italia 204
BR - Brasile 144
CA - Canada 117
RU - Federazione Russa 104
SN - Senegal 90
DE - Germania 67
CI - Costa d'Avorio 59
SE - Svezia 58
KR - Corea 37
GB - Regno Unito 21
CH - Svizzera 19
FR - Francia 16
IN - India 14
UZ - Uzbekistan 14
AT - Austria 13
VN - Vietnam 10
BD - Bangladesh 8
NL - Olanda 8
FI - Finlandia 7
ES - Italia 6
PL - Polonia 6
AR - Argentina 5
JP - Giappone 5
MX - Messico 5
TR - Turchia 5
ZA - Sudafrica 5
EU - Europa 4
GR - Grecia 4
PK - Pakistan 4
BE - Belgio 3
JO - Giordania 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
DZ - Algeria 2
IQ - Iraq 2
JM - Giamaica 2
LB - Libano 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HK - Hong Kong 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
LT - Lituania 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PW - Palau 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TV - Tuvalu 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.432
Salva come PNG Salva come JPEG
Città #
Santa Clara 664
Jacksonville 345
Singapore 336
Dublin 306
Chandler 292
Ashburn 287
Chicago 154
Boardman 141
Nanjing 92
Dakar 90
Cambridge 88
Lawrence 87
Toronto 87
Andover 83
Beijing 76
Abidjan 59
Civitanova Marche 51
San Mateo 50
Nanchang 44
Des Moines 41
Wilmington 39
Bremen 32
Hebei 28
Tianjin 27
Changsha 24
Saint Petersburg 24
Shenyang 24
Hefei 21
Ottawa 19
Jiaxing 18
Seoul 18
Seongnam 17
Taormina 16
Munich 15
São Paulo 15
Moscow 13
Council Bluffs 12
Los Angeles 12
Jinan 8
New York 8
Seattle 8
Catania 7
Milan 7
Tashkent 7
The Dalles 7
Columbus 6
Helsinki 6
Naples 6
Ningbo 6
Rome 6
Zhengzhou 6
Ann Arbor 5
Brooklyn 5
Campinas 5
Den Haag 5
Hangzhou 5
Norwalk 5
Tokyo 5
Charlotte 4
Dong Ket 4
Frankfurt Am Main 4
Kunming 4
Montreal 4
Phoenix 4
Pune 4
Amman 3
Bari 3
Brussels 3
Caxias do Sul 3
Curitiba 3
Lausanne 3
San Francisco 3
San Giovanni la Punta 3
Scafa 3
Turin 3
Vienna 3
Warsaw 3
Amantea 2
Ankara 2
Assago 2
Avola 2
Belo Horizonte 2
Blumenau 2
Bologna 2
Boston 2
Brasília 2
Calgary 2
Campo Largo 2
Cologno Al Serio 2
Colombo 2
Conceição do Mato Dentro 2
Denver 2
Dhaka 2
Durban 2
Goiânia 2
Hanoi 2
Kiev 2
Lahore 2
Lanzhou 2
Liberty Lake 2
Totale 3.980
Salva come PNG Salva come JPEG
Nome #
Intracesarean removal of two huge fibroids occupying the whole uterine fundus: A case report 288
EFFICACIA CLINICA DELLA N-OLEIL-FOSFATIDIL-ETANOLAMINA (NOPE) NELLA TERAPIA DELL’OBESITA’: NOSTRA ESPERIENZA 108
A specific application of locus of control of behaviour scale on patients with pelvic floor alteration 91
Acetyl-L-Carnitine in the treatment of patients with weight-loss related to hypothalamic amenorrhea 89
Effects of Myo-Inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial 88
D-Chiro-Inositol treatment in patients with polycystic ovary syndrome 88
ASPETTI PSICHICI DELLA SINDROME PREMESTRUALE (PMS) E DISTURBO DISFORICO DELLA FASE LUTEALE (PMDD): NUOVE PROSPETTIVE TERAPEUTICHE, IL VITEX AGNUS CASTUS (VAC) : NOSTRE ESPERIENZE 86
Hydronephrosis and utero-vaginal prolapse in postmenopausal women: management and treatment 85
Adolescents and PCOS: Last update on diagnosis and therapy 85
Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance 81
PCOS treatment with an oral contraceptive containing Drospirenone, alone or in association with D-Chiro-Inositol 81
Clinical and endocrine effects of finasteride, a 5a-reductase inhibitor, in women with idiopathic hirsutism 79
L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history 76
Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease 76
Contraccezione orale con estro-progestinici e sviluppo di mastopatie benigne 76
Adrenal steroid secretion in postmenopausal women during raloxifene therapy 75
Diabete in Gravidanza: Focus sulle Complicanze 75
Clinical affects of finasteride , 5-a-reductase inhibitor in post menopausal women with hair loss 74
Clomiphene citrate and dydrogesterone: a combined therapy for functional hypothalamic amenorrhea 74
Correlation between thyroid function and post-partum depression: preliminary dates on sample study 73
Protection of ovarian tissue from radiotherapy 73
Terapia ormonale sostitutiva: effetti sull’endometrio in donne a rischio di adenocarcinoma endometriale 72
Myo-inositol vs D-Chiro-Inositol in PCOS treatment 72
TERAPIA DEL DIABETE GESTAZIONALE: GLI ATTUALI APPROCCI 72
Effects of inositol on oocytes’ quality in patients with polycystic ovary syndrome 70
Studio prospettivo sulla riparazione del cistocele con allografts in derma porcino tipo Pelvisoft (Bard Urological) 69
B19 Parvovirus non-immune hydrops fetalis: a case report. 69
The efficacy of a pollen extract as non estrogenic alternative to hormone replacement therapy in symptomatic perimenopausal women 68
Screening for preeclampsia by uterine artery Doppler velocimetry in the late first trimester of pregnancy 66
Effects of genisteina and daidzeina in climateric symptoms and postmenopausal bone loss 66
Aspetti metabolici ed epatici della policistosi ovarica 66
Iter diagnostico e terapeutico delle amenorre 64
The reproduction in women affected by cooley disease 64
Influence of sport and low animal saturated fats intake diet on lipid dismetabolisms in postmenopausal women 63
Laparoscopic removal of a giant paratubal cyst complicated by hydronephrosis 63
Original study: role of BMP-15 in the pathogenesis of premature ovarian failure (POF) 61
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 60
Effetti del trattamento con metaformina sulla distribuzione corporea dell'adipe, sul profilo lipidico e sulla risposta insulinemica in donne affette da sindrome dell'ovaio policistico 59
Uterine bleeding pattern during low dosage Noretisterone acetate and 17-b-Estradiol treatment in postmenopausal patients 58
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 57
Efficacia e sicurezza del nuovo contraccettivo orale antiandrogeno contenente Clormadinone Acetato (Belaro) follow up a 12 mesi 57
Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia 57
Male equivalent polycystic ovarian syndrome: Hormonal, metabolic and clinical aspects 55
Pseudoachantosis nigricans: a skin maker for hyperinulinemia 54
Tolleranza clinica e metabolica del trattamento long-term con alendronato (70 mg) 53
Influence of HRT on body mass index, arterial pressure profile and lipidic metabolism in postmenopausal women 53
Efficacia dell’a-tocoferolo acetato (100% vitamina E) per via vaginale nella prevenzione delle erosioni dopo riparazione protesica del prolasso urogenitale 53
Medical therapy for endometriosis: a literature review. 53
Oral contraception and benign breast disease 52
Trattamento topico dell’irsutismo facciale con eflornitina in donne in post-menopausa 52
Oral Contraception and Breast Diseases. 51
Fisiologia delle amenoree 51
Innovative genetic, clinical and endocrinological aspects in young females affected with premature ovarian insufficiency 51
Induction of ovulation in thalassemic patients 51
EFFETTI CLINICI DEL TRATTAMENTO CON FITOESTROGENI IN DONNE IN POST-MENOPAUSA 50
Low birth-weight is a PCOS risk factor for Southern-Italian women 50
Metabolismo osseo in donne in postmenopausa in trattamento con fitoestrogeni 50
Profili lipidici ed emocoagulativi in donne in postmenopausa in trattamento con raloxifene 50
Weight change and adverse event incidence with a different combined estradiol-progestin regimens in postmenopausal women 50
Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease 50
Effetti sul metabolismo lipidico e sui parametri emocoagulativi della terapia con raloxifene in donne osteoporotiche in postmenopausa 49
Effetti della terapia con metformina in pazienti obese con PCOS 49
Risultati clinici e metabolici durante il trattamento con Alendronato con somministrazione settimanale 48
Problematiche terapeutiche in donne affette da POF (premature ovarian faiilure) 48
Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients 48
Hydronephrosis due to voluminous adnexial mass in a teenager: management and treatment 47
ISOLATED ELEVATED LIVER ENZYME AT 28°WEEK OF GESTATION: A CASE REPORT 46
Trattamento "long-term" con dosi ridotte di flutamide nella prevenzione della recidive sitomatologiche in pazieti con PCOS 46
Evaluation of thyroid function at delivery and in the first 6 months postpartum: preliminary data in a Sicilian Sample study 46
Procreazione Medicalmente Assistita ed Endometriosi 45
Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women 45
Assisted reproduction in women affected by endometriosis: Our experience [Procreazione medicalmente assistita nelle pazienti affette da endometriosi: La nostra esperienza] 44
Subclinical hypothyroidism among subjective and objective symptoms in menopause transition: prevalence and incidence 44
Incidenza di eventi avversi durante terapia con dose monosettimanale (70 mg) o giornaliera (10 mg) di alendronato in donne osteopeniche in postmenopausa 44
Effetti della genisteina e daidzeina sui sintomi climaterici e sulla perdita ossea in donne in postmenopausa 44
Therapetic strategies in women affected by premature ovarian failure 42
Metabolic Aspects of PCOS Treatment with Insulin Sensitizers 41
Efficacy of Cimicifuga Racemosa on Menopausal Symptoms in Women with Breast Cancer 40
Relationship between tumour necrosis factor alpha and sex steroid concentrations in the follicular fluid of women with immunological infertility 40
Patologia mammaria benigna e gravidanza 40
Fertility after multiple myomectomy 39
Effetti del Myo-inositolo sulla qualità ovocitaria in pazienti affette da Sindrome dell’Ovaio Policistico 39
Effetti della genisteina sulla perdita ossea in donne in post menopausa 37
Trattamento con Gn-RH analogo per la protezione del potenziale riproduttivo in giovani donne affette da linfoma di Hodking e non Hodking 37
Role of DEXA and ultrasonometry in the evaluation of osteoporotic risk in postmenopausal women 37
Profili lipidici ed emocoagulativi in donne in postmenopausa in trattamento con raloxifene 2008 37
Monoprotesi per il trattamento simultaneo del cistocele e dell’incontinenza urinaria da stress (protocollo NAZCA): studio prospettico 36
Genetics pathogenesis in the ovarian insufficiency 36
Long-term treatement with low-dose flutamide in the syntomatic relapses prevention of patient suffering from PCOS 34
Il carcinoma mammario e gravidanza 33
Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome [Effetti dell'inositolo sulla qualità ovocitaria in pazienti affette da sindrome dell'ovaio policistico] 32
Problematiche terapeutiche in donne affette da POF (premature ovarian failure) 31
Totale 5.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.941
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021532 0 55 90 1 150 11 60 2 51 2 80 30
2021/2022623 86 91 4 10 95 1 84 23 68 0 27 134
2022/2023989 90 55 12 101 80 166 2 205 243 6 19 10
2023/2024561 19 58 9 32 19 60 1 246 0 5 65 47
2024/20251.798 14 293 96 62 505 286 6 42 109 148 92 145
2025/2026253 247 6 0 0 0 0 0 0 0 0 0 0
Totale 5.527